A Randomized Trial Comparing Bangerter Filters and Patching for the Treatment of Moderate Amblyopia in Children
To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Randomized, clinical trial. We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80). Children were ran...
Saved in:
Published in | Ophthalmology (Rochester, Minn.) Vol. 117; no. 5; pp. 998 - 1004.e6 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.05.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia.
Randomized, clinical trial.
We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80).
Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks.
Visual acuity in amblyopic eyes at 24 weeks.
At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved ≥3 lines (Bangerter group 38% vs patching group 35%;
P = 0.61) or had ≥20/25 amblyopic eye acuity (36% vs 31%, respectively;
P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement.
Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia.
The authors have no proprietary or commercial interest in any of the materials discussed in this article. |
---|---|
AbstractList | To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia.
Randomized, clinical trial.
We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40-20/80).
Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks.
Visual acuity in amblyopic eyes at 24 weeks.
At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved > or =3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had > or =20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement.
Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia.OBJECTIVETo determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia.Randomized, clinical trial.DESIGNRandomized, clinical trial.We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40-20/80).PARTICIPANTSWe enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40-20/80).Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks.METHODSChildren were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks.Visual acuity in amblyopic eyes at 24 weeks.MAIN OUTCOME MEASURESVisual acuity in amblyopic eyes at 24 weeks.At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved > or =3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had > or =20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement.RESULTSAt 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved > or =3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had > or =20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement.Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia.CONCLUSIONSBecause the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. Objective To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Design Randomized, clinical trial. Participants We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80). Methods Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks. Main Outcome Measures Visual acuity in amblyopic eyes at 24 weeks. Results At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved ≥3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had ≥20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement. Conclusions Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. Financial Disclosure(s) The authors have no proprietary or commercial interest in any of the materials discussed in this article. To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Randomized, clinical trial. We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80). Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks. Visual acuity in amblyopic eyes at 24 weeks. At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved ≥3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had ≥20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement. Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. The authors have no proprietary or commercial interest in any of the materials discussed in this article. |
Author | Leske, David A Bonsall, Dean J Repka, Michael X Rutstein, Robert P Quinn, Graham E Cotter, Susan A Lazar, Elizabeth L Holmes, Jonathan M Crouch, Eric R Suh, Donny W Beck, Roy W Lorenzana, Ingryd J Hoover, Darren L |
AuthorAffiliation | Jaeb Center for Health Research, Tampa, FL 33647, USA |
AuthorAffiliation_xml | – name: Jaeb Center for Health Research, Tampa, FL 33647, USA |
Author_xml | – sequence: 1 givenname: Robert P surname: Rutstein fullname: Rutstein, Robert P – sequence: 2 givenname: Graham E surname: Quinn fullname: Quinn, Graham E – sequence: 3 givenname: Elizabeth L surname: Lazar fullname: Lazar, Elizabeth L – sequence: 4 givenname: Roy W surname: Beck fullname: Beck, Roy W – sequence: 5 givenname: Dean J surname: Bonsall fullname: Bonsall, Dean J – sequence: 6 givenname: Susan A surname: Cotter fullname: Cotter, Susan A – sequence: 7 givenname: Eric R surname: Crouch fullname: Crouch, Eric R – sequence: 8 givenname: Jonathan M surname: Holmes fullname: Holmes, Jonathan M – sequence: 9 givenname: Darren L surname: Hoover fullname: Hoover, Darren L – sequence: 10 givenname: David A surname: Leske fullname: Leske, David A – sequence: 11 givenname: Ingryd J surname: Lorenzana fullname: Lorenzana, Ingryd J – sequence: 12 givenname: Michael X surname: Repka fullname: Repka, Michael X – sequence: 13 givenname: Donny W surname: Suh fullname: Suh, Donny W |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22773755$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20163869$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkl2PEyEUholZ43ZX_4Ex3BivpsLAzDDGbFIbV03WaHS9JhTOdKgzUIFuUn-9TFrXj8RsvAFyznPew-HlDJ047wChx5TMKaH1883cb_vUq3lJSJtDc0L5PTSjFW8L3lB2gmYZo0XNS3KKzmLcEELqmvEH6LTMGSbqdob8An9SzvjRfgeDr4NVA176cauCdWv8Srk1hAQBX9ohbxFnFn9USfdTuvMBpx5yGag0gkvYd_i9NxBUArwYV8Peb63C1uFlbwcTwD1E9zs1RHh03M_Rl8vX18u3xdWHN--Wi6tC14SkQjWsXHUmr01jhK5aEGAElFCBqGvBCYAQatXxTgMrSUM4U6tG85ZCPlSGnaOLg-52txrB6Hy5oAa5DXZUYS-9svLPjLO9XPsbWYqaMyaywLOjQPDfdhCTHG3UMAzKgd9F2TBW0ZrQJpNPfm912-PnI2fg6RFQUauhC8ppG39xeUbWVFXm-IHTwccYoLtFKJGT53IjD57LyfMpmj3PZS_-KtM2qWT9NJgd7io-vhNkM24sBBm1BafB2AA6SePt_wrowTqb5_wKe4gbvwsuGy2pjKUk8vP0J6cvSVpCqahYFnj5b4G7-_8ADL70zA |
CODEN | OPHTDG |
CitedBy_id | crossref_primary_10_1016_j_jaapos_2010_04_004 crossref_primary_10_4103_sjopt_sjopt_212_23 crossref_primary_10_1155_2015_909848 crossref_primary_10_3368_aoj_66_1_87 crossref_primary_10_4103_ijo_IJO_852_22 crossref_primary_10_1016_S0140_6736_14_60522_5 crossref_primary_10_1016_j_ophtha_2017_10_008 crossref_primary_10_1364_BOE_424715 crossref_primary_10_3389_fnins_2021_622729 crossref_primary_10_1002_jmri_26708 crossref_primary_10_1007_s00417_010_1564_x crossref_primary_10_1097_OPX_0b013e31826c5e06 crossref_primary_10_3390_children9020205 crossref_primary_10_1111_opo_12992 crossref_primary_10_1186_s12886_017_0624_y crossref_primary_10_1016_j_jaapos_2024_103991 crossref_primary_10_1016_j_visres_2018_04_005 crossref_primary_10_1016_j_visres_2015_05_015 crossref_primary_10_4103_jcor_jcor_75_24 crossref_primary_10_1016_j_ophtha_2022_10_020 crossref_primary_10_1136_bjophthalmol_2013_303350 crossref_primary_10_3390_ijerph20031751 crossref_primary_10_1016_j_jaapos_2011_06_007 crossref_primary_10_1016_j_jaapos_2011_02_003 crossref_primary_10_1016_j_preteyeres_2023_101168 crossref_primary_10_1093_jpepsy_jst009 crossref_primary_10_1364_JOSAA_30_001441 crossref_primary_10_1364_BOE_489585 crossref_primary_10_3389_fnins_2019_01364 crossref_primary_10_1017_S0952523817000220 crossref_primary_10_1007_s00417_019_04254_w crossref_primary_10_1016_j_ophtha_2013_04_008 crossref_primary_10_3368_aoj_63_1_14 crossref_primary_10_1111_cxo_12553 crossref_primary_10_1371_journal_pone_0237346 crossref_primary_10_1111_opo_13395 crossref_primary_10_1016_j_survophthal_2024_04_006 crossref_primary_10_1016_j_yaoo_2016_03_007 crossref_primary_10_1038_s41598_023_45057_8 crossref_primary_10_1080_09273972_2019_1618351 crossref_primary_10_1097_ICU_0000000000000409 crossref_primary_10_1155_2019_5157628 crossref_primary_10_1016_j_visres_2020_07_014 crossref_primary_10_1007_s00417_016_3334_x crossref_primary_10_1002_14651858_CD006461_pub4 crossref_primary_10_1016_j_survophthal_2023_01_001 crossref_primary_10_1155_2019_5857243 crossref_primary_10_1038_eye_2011_4 crossref_primary_10_1186_s12886_022_02246_9 crossref_primary_10_1016_j_ajo_2020_07_053 crossref_primary_10_3760_cma_j_issn_0366_6999_20132998 crossref_primary_10_1007_s00417_021_05231_y crossref_primary_10_1111_j_1755_3768_2011_02227_x crossref_primary_10_1146_annurev_vision_100720_022550 crossref_primary_10_3389_fnins_2022_804576 crossref_primary_10_1080_09273972_2021_1914677 crossref_primary_10_1080_09273972_2022_2046114 crossref_primary_10_1016_j_preteyeres_2012_11_001 crossref_primary_10_1177_27536351241297249 crossref_primary_10_1007_s10792_023_02642_0 crossref_primary_10_1016_j_jaapos_2014_09_009 crossref_primary_10_1002_14651858_CD005136_pub3 crossref_primary_10_1016_j_ajo_2024_08_011 crossref_primary_10_3109_02713683_2015_1011280 crossref_primary_10_1002_14651858_CD005136_pub4 crossref_primary_10_1007_s40123_021_00394_7 crossref_primary_10_1016_j_visres_2015_02_012 crossref_primary_10_1016_j_ophtha_2011_06_043 crossref_primary_10_1016_j_ophtha_2011_06_041 crossref_primary_10_1080_02713683_2023_2275531 crossref_primary_10_1167_iovs_66_1_4 crossref_primary_10_1038_s41433_021_01669_w crossref_primary_10_3368_aoj_62_1_1 crossref_primary_10_1016_j_survophthal_2022_08_003 crossref_primary_10_1167_iovs_65_3_33 crossref_primary_10_1186_s12886_018_0922_z crossref_primary_10_1038_s41598_022_08010_9 crossref_primary_10_2147_OPTO_S454342 crossref_primary_10_1007_s10633_014_9462_x crossref_primary_10_1016_j_ophtha_2022_06_016 crossref_primary_10_1016_j_jaapos_2010_11_015 crossref_primary_10_1097_OPX_0000000000001514 crossref_primary_10_1097_OPX_0000000000001431 crossref_primary_10_1007_s00417_017_3851_2 crossref_primary_10_1080_09273972_2019_1601743 crossref_primary_10_1016_j_ophtha_2011_12_003 crossref_primary_10_1016_j_visres_2015_01_029 |
Cites_doi | 10.3368/aoj.51.1.84 10.1001/archopht.121.11.1625 10.1001/archopht.119.9.1345 10.1001/archopht.121.5.603 10.1001/archopht.123.4.437 10.1016/j.ophtha.2006.01.069 10.1001/archophthalmol.2008.520 10.1001/archopht.120.3.268 10.1016/S0002-9394(02)01825-1 10.1016/j.ophtha.2004.04.032 10.1016/j.jaapos.2008.04.017 10.1111/j.2517-6161.1972.tb00899.x 10.1016/j.jaapos.2008.04.012 10.1016/j.ophtha.2009.02.023 10.1001/archophthalmol.2008.107 10.1067/mpa.2001.117097 |
ContentType | Journal Article |
Copyright | 2010 American Academy of Ophthalmology American Academy of Ophthalmology 2015 INIST-CNRS Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2010 American Academy of Ophthalmology – notice: American Academy of Ophthalmology – notice: 2015 INIST-CNRS – notice: Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
CorporateAuthor | Pediatric Eye Disease Investigator Group Writing Committee |
CorporateAuthor_xml | – name: Pediatric Eye Disease Investigator Group Writing Committee |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.ophtha.2009.10.014 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1549-4713 |
EndPage | 1004.e6 |
ExternalDocumentID | PMC2864338 20163869 22773755 10_1016_j_ophtha_2009_10_014 S0161642009011853 1_s2_0_S0161642009011853 |
Genre | Multicenter Study Comparative Study Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Eye Institute of National Institutes of Health, Department of Health and Human Services grantid: EY011751 – fundername: NEI NIH HHS grantid: UG1 EY011751 – fundername: NEI NIH HHS grantid: U10 EY011751 – fundername: NEI NIH HHS grantid: EY011751 |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1B1 1CY 1P~ 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAXUO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ABWVN ACGFO ACGFS ACIUM ACNCT ACRPL ACVFH ADCNI ADMUD ADNMO AEFWE AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AGCQF AGQPQ AIGII AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY C5W CS3 DU5 EBS EFJIC EFKBS EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M27 M41 MO0 N4W N9A NQ- O9- OF- OPF OQ~ P2P R2- ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZGI ZXP ADPAM RIG AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c600t-a732bfd73277d8c59e8ed8e2e5e866840ee88abf4fce3207043ab7c491e3ab5d3 |
ISSN | 0161-6420 1549-4713 |
IngestDate | Thu Aug 21 14:01:24 EDT 2025 Fri Jul 11 04:33:47 EDT 2025 Mon Jul 21 05:54:50 EDT 2025 Mon Jul 21 09:14:18 EDT 2025 Sun Jul 06 05:03:22 EDT 2025 Thu Apr 24 23:06:15 EDT 2025 Fri Feb 23 02:14:51 EST 2024 Sun Feb 23 10:19:59 EST 2025 Tue Aug 26 19:03:10 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Human Eye disease Treatment Filter Vision disorder Amblyopia Ophthalmology Child Comparative study |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c600t-a732bfd73277d8c59e8ed8e2e5e866840ee88abf4fce3207043ab7c491e3ab5d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | http://www.aaojournal.org/article/S0161642009011853/pdf |
PMID | 20163869 |
PQID | 733516017 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2864338 proquest_miscellaneous_733516017 pubmed_primary_20163869 pascalfrancis_primary_22773755 crossref_primary_10_1016_j_ophtha_2009_10_014 crossref_citationtrail_10_1016_j_ophtha_2009_10_014 elsevier_sciencedirect_doi_10_1016_j_ophtha_2009_10_014 elsevier_clinicalkeyesjournals_1_s2_0_S0161642009011853 elsevier_clinicalkey_doi_10_1016_j_ophtha_2009_10_014 |
PublicationCentury | 2000 |
PublicationDate | 2010-05-01 |
PublicationDateYYYYMMDD | 2010-05-01 |
PublicationDate_xml | – month: 05 year: 2010 text: 2010-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Ophthalmology (Rochester, Minn.) |
PublicationTitleAlternate | Ophthalmology |
PublicationYear | 2010 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Lang (bib5) 1999; 14 (bib11) 2003; 121 (bib12) 2005; 123 (bib3) 2009; 127 (bib18) 2003; 121 Verbeke, Molenberghs (bib14) 2000 Odell, Leske, Hatt (bib17) 2008; 12 Cox (bib15) 1972; 34 (bib1) 2002; 120 Holmes, Beck, Repka (bib7) 2001; 119 Holmes, Strauber, Quinn (bib10) 2008; 12 Iacobucci, Archer, Furr (bib6) 2001; 51 (bib16) 2004; 111 Beck, Moke, Turpin (bib8) 2003; 135 Agervi, Kugelberg, Kugelberg (bib19) 2009; 116 (bib2) 2008; 126 (bib13) 2006; 113 Cole, Beck, Moke (bib9) 2001; 5 Bangerter (bib4) 1960; 136 Verbeke (10.1016/j.ophtha.2009.10.014_bib14) 2000 Odell (10.1016/j.ophtha.2009.10.014_bib17) 2008; 12 (10.1016/j.ophtha.2009.10.014_bib3) 2009; 127 (10.1016/j.ophtha.2009.10.014_bib12) 2005; 123 (10.1016/j.ophtha.2009.10.014_bib1) 2002; 120 (10.1016/j.ophtha.2009.10.014_bib16) 2004; 111 Holmes (10.1016/j.ophtha.2009.10.014_bib7) 2001; 119 Holmes (10.1016/j.ophtha.2009.10.014_bib10) 2008; 12 (10.1016/j.ophtha.2009.10.014_bib18) 2003; 121 Cole (10.1016/j.ophtha.2009.10.014_bib9) 2001; 5 Beck (10.1016/j.ophtha.2009.10.014_bib8) 2003; 135 (10.1016/j.ophtha.2009.10.014_bib2) 2008; 126 Agervi (10.1016/j.ophtha.2009.10.014_bib19) 2009; 116 Bangerter (10.1016/j.ophtha.2009.10.014_bib4) 1960; 136 Lang (10.1016/j.ophtha.2009.10.014_bib5) 1999; 14 Cox (10.1016/j.ophtha.2009.10.014_bib15) 1972; 34 Iacobucci (10.1016/j.ophtha.2009.10.014_bib6) 2001; 51 (10.1016/j.ophtha.2009.10.014_bib11) 2003; 121 (10.1016/j.ophtha.2009.10.014_bib13) 2006; 113 |
References_xml | – volume: 127 start-page: 22 year: 2009 end-page: 30 ident: bib3 article-title: Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial publication-title: Arch Ophthalmol – volume: 12 start-page: 581 year: 2008 end-page: 584 ident: bib10 article-title: Further validation of the Amblyopia Treatment Index parental questionnaire publication-title: J AAPOS – volume: 135 start-page: 194 year: 2003 end-page: 205 ident: bib8 article-title: A computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol publication-title: Am J Ophthalmol – volume: 34 start-page: 187 year: 1972 end-page: 220 ident: bib15 article-title: Regression models and life-tables publication-title: J R Stat Soc Ser B – volume: 12 start-page: 555 year: 2008 end-page: 559 ident: bib17 article-title: The effect of Bangerter filters on optotype acuity, Vernier acuity, and contrast sensitivity publication-title: J AAPOS – volume: 120 start-page: 268 year: 2002 end-page: 278 ident: bib1 article-title: A randomized trial of atropine vs patching for treatment of moderate amblyopia in children publication-title: Arch Ophthalmol – volume: 14 start-page: 9 year: 1999 end-page: 10 ident: bib5 article-title: An efficient treatment and new criteria for cure of strabismic amblyopia: reading and Bangerter foils publication-title: Binocul Vis Strabismus Q – volume: 123 start-page: 437 year: 2005 end-page: 447 ident: bib12 article-title: Randomized trial of treatment of amblyopia in children aged 7 to 17 years publication-title: Arch Ophthalmol – volume: 51 start-page: 84 year: 2001 end-page: 91 ident: bib6 article-title: Bangerter foils in the treatment of moderate amblyopia publication-title: Am Orthopt J – volume: 121 start-page: 1625 year: 2003 end-page: 1632 ident: bib18 article-title: Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study publication-title: Arch Ophthalmol – volume: 126 start-page: 1634 year: 2008 end-page: 1642 ident: bib2 article-title: Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial publication-title: Arch Ophthalmol – volume: 116; start-page: 1475 year: 2009 end-page: 1480 ident: bib19 article-title: Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters publication-title: Ophthalmology – volume: 111 start-page: 2076 year: 2004 end-page: 2085 ident: bib16 article-title: A randomized trial of atropine regimens for treatment of moderate amblyopia in children publication-title: Ophthalmology – volume: 119 start-page: 1345 year: 2001 end-page: 1353 ident: bib7 article-title: The Amblyopia Treatment Study visual acuity testing protocol publication-title: Arch Ophthalmol – volume: 121 start-page: 603 year: 2003 end-page: 611 ident: bib11 article-title: A randomized trial of patching regimens for treatment of moderate amblyopia in children publication-title: Arch Ophthalmol – volume: 113 start-page: 904 year: 2006 end-page: 912 ident: bib13 article-title: A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children publication-title: Ophthalmology – volume: 136 start-page: 305 year: 1960 end-page: 331 ident: bib4 article-title: Occlusion in pleoptics and orthoptics publication-title: Klin Monatsblatter Augenheilkd Augenarztl Fortbild – volume: 5 start-page: 250 year: 2001 end-page: 254 ident: bib9 article-title: The Amblyopia Treatment Index publication-title: J AAPOS – start-page: 41 year: 2000 end-page: 42 ident: bib14 article-title: Linear Mixed Models for Longitudinal Data – volume: 51 start-page: 84 year: 2001 ident: 10.1016/j.ophtha.2009.10.014_bib6 article-title: Bangerter foils in the treatment of moderate amblyopia publication-title: Am Orthopt J doi: 10.3368/aoj.51.1.84 – volume: 121 start-page: 1625 year: 2003 ident: 10.1016/j.ophtha.2009.10.014_bib18 article-title: Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study publication-title: Arch Ophthalmol doi: 10.1001/archopht.121.11.1625 – volume: 14 start-page: 9 year: 1999 ident: 10.1016/j.ophtha.2009.10.014_bib5 article-title: An efficient treatment and new criteria for cure of strabismic amblyopia: reading and Bangerter foils publication-title: Binocul Vis Strabismus Q – volume: 119 start-page: 1345 year: 2001 ident: 10.1016/j.ophtha.2009.10.014_bib7 article-title: The Amblyopia Treatment Study visual acuity testing protocol publication-title: Arch Ophthalmol doi: 10.1001/archopht.119.9.1345 – volume: 121 start-page: 603 year: 2003 ident: 10.1016/j.ophtha.2009.10.014_bib11 article-title: A randomized trial of patching regimens for treatment of moderate amblyopia in children publication-title: Arch Ophthalmol doi: 10.1001/archopht.121.5.603 – volume: 123 start-page: 437 year: 2005 ident: 10.1016/j.ophtha.2009.10.014_bib12 article-title: Randomized trial of treatment of amblyopia in children aged 7 to 17 years publication-title: Arch Ophthalmol doi: 10.1001/archopht.123.4.437 – start-page: 41 year: 2000 ident: 10.1016/j.ophtha.2009.10.014_bib14 article-title: Linear Mixed Models for Longitudinal Data – volume: 113 start-page: 904 year: 2006 ident: 10.1016/j.ophtha.2009.10.014_bib13 article-title: A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.01.069 – volume: 127 start-page: 22 year: 2009 ident: 10.1016/j.ophtha.2009.10.014_bib3 article-title: Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2008.520 – volume: 136 start-page: 305 year: 1960 ident: 10.1016/j.ophtha.2009.10.014_bib4 article-title: Occlusion in pleoptics and orthoptics publication-title: Klin Monatsblatter Augenheilkd Augenarztl Fortbild – volume: 120 start-page: 268 year: 2002 ident: 10.1016/j.ophtha.2009.10.014_bib1 article-title: A randomized trial of atropine vs patching for treatment of moderate amblyopia in children publication-title: Arch Ophthalmol doi: 10.1001/archopht.120.3.268 – volume: 135 start-page: 194 year: 2003 ident: 10.1016/j.ophtha.2009.10.014_bib8 article-title: A computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(02)01825-1 – volume: 111 start-page: 2076 year: 2004 ident: 10.1016/j.ophtha.2009.10.014_bib16 article-title: A randomized trial of atropine regimens for treatment of moderate amblyopia in children publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.04.032 – volume: 12 start-page: 581 year: 2008 ident: 10.1016/j.ophtha.2009.10.014_bib10 article-title: Further validation of the Amblyopia Treatment Index parental questionnaire publication-title: J AAPOS doi: 10.1016/j.jaapos.2008.04.017 – volume: 34 start-page: 187 year: 1972 ident: 10.1016/j.ophtha.2009.10.014_bib15 article-title: Regression models and life-tables publication-title: J R Stat Soc Ser B doi: 10.1111/j.2517-6161.1972.tb00899.x – volume: 12 start-page: 555 year: 2008 ident: 10.1016/j.ophtha.2009.10.014_bib17 article-title: The effect of Bangerter filters on optotype acuity, Vernier acuity, and contrast sensitivity publication-title: J AAPOS doi: 10.1016/j.jaapos.2008.04.012 – volume: 116; start-page: 1475 year: 2009 ident: 10.1016/j.ophtha.2009.10.014_bib19 article-title: Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters publication-title: Ophthalmology doi: 10.1016/j.ophtha.2009.02.023 – volume: 126 start-page: 1634 year: 2008 ident: 10.1016/j.ophtha.2009.10.014_bib2 article-title: Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2008.107 – volume: 5 start-page: 250 year: 2001 ident: 10.1016/j.ophtha.2009.10.014_bib9 article-title: The Amblyopia Treatment Index publication-title: J AAPOS doi: 10.1067/mpa.2001.117097 |
SSID | ssj0006634 |
Score | 2.3428614 |
Snippet | To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate... Objective To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 998 |
SubjectTerms | Amblyopia - physiopathology Amblyopia - therapy Biological and medical sciences Child Child, Preschool Eyeglasses Female Humans Male Medical sciences Miscellaneous Occlusive Dressings Ophthalmology Sensory Deprivation Treatment Outcome Vision disorders Visual Acuity - physiology |
Title | A Randomized Trial Comparing Bangerter Filters and Patching for the Treatment of Moderate Amblyopia in Children |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0161642009011853 https://www.clinicalkey.es/playcontent/1-s2.0-S0161642009011853 https://dx.doi.org/10.1016/j.ophtha.2009.10.014 https://www.ncbi.nlm.nih.gov/pubmed/20163869 https://www.proquest.com/docview/733516017 https://pubmed.ncbi.nlm.nih.gov/PMC2864338 |
Volume | 117 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZbCmNQxq5ddil62FtxsGXLkh-zslJWuo2Ssr4ZyZaJS2KHJX1of_2OrEucLiPdXoziWLGd8_lc5POdg9CnTPKMpxkEOTAKElqRQJBUBLLkismSVFGoycnn39LTy-TrFb1y_e4tu2QlR8XdVl7J_0gV9oFcNUv2HyTrfxR2wBjkC1uQMGwfJOPx0YVoynZe34HbOOn6bxybvoIQ_3_uGL26BuJJrV-Jm2LMP0D1-uxJ7XROfKa5TobRndHA-zwaz-Xstl3UomMFWsJ335H9vpiupmI2NyWcunUI23rLJOM3zcgtMtg1BfM6vLem4Mgu_XXHNAogVAk3FKdhXVqE0J4azExnaWtRdVG6rdraLBxcj9rukk3xUJ1qZ2ilm8Wx7xktn0pICGMxo_Qx2oMRIQO0Nz67-HnmzTG4VLbAu7kDx5_skvz-PPPf_JP9hVjCU1OZdifb4pH7abU9P2XyHD2zAQYeG7S8QI9U8xI9ObcpFK9QO8Zr0OAONNiDBnvQYAsaDMdiBxoMoMEAGuxBg9sKO9BgDxpcN9iB5jW6PPkyOT4NbNeNoADndxUIFhNZlbBlrOQFzRRX8OASRRVPdWkgpTgXskqqQsUELEYSC8mKJIsUDGgZv0GDpm3UW4QZ0VNEqUjGwS2XoAAK-Mi4CiWhSTlEsfuv88KWpNedUWa5yz28zo2EdLfUTO8FCQ1R4GctTEmWHcdTJ8bc0Y3BQOaAwh3z2LZ5amk1wDKP8iXJQ50gmUYaWmHH46Zxf6Z1ZI2D-oBzHm7gzN-gg_kQYQe8HAyBfrsnGtXeLHMWxzRKwcAO0YHB4XpyqKOuNIPr2kCoP0DXmN_8pqmnXa15wiFkifm7Xdf1Hj1dK5IPaLD6daM-gru-kof2gfwNv4vvKw |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Randomized+Trial+Comparing+Bangerter+Filters+and+Patching+for+the+Treatment+of+Moderate+Amblyopia+in+Children&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.date=2010-05-01&rft.pub=Elsevier&rft.issn=0161-6420&rft.volume=117&rft.issue=5&rft.spage=998&rft.epage=1004&rft_id=info:doi/10.1016%2Fj.ophtha.2009.10.014&rft.externalDBID=n%2Fa&rft.externalDocID=22773755 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642009X00187%2Fcov150h.gif |